Product Portfolio

Amryt Pharma is committed to delivering safe, effective and innovative medicines that treat extremely rare and life-threatening diseases; transforming lives where it may not have been possible in the past. Our portfolio of specialist therapies includes products that we plan to make available to people with rare diseases across the world.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Reporting forms and information can be found on the MHRA Yellow Card reporting site.
Adverse events should also be reported to Amryt Pharmaceuticals DAC on:
Tel: +44 1604 549 952 or Freephone Number +800 4447 4447
E-mail: medinfo@amrytpharma.com